Switch Language
Alt tag

Adviser’s Picks 2020

Can the risk of vascular events be reduced in patients with peripheral artery disease undergoing lower-extremity endovascular revascularization?

Can the risk of vascular events be reduced in patients with peripheral artery disease undergoing lower-extremity endovascular revascularization?

Can the risk of vascular events be reduced in patients with peripheral artery disease undergoing lower-extremity endovascular revascularization?

Enhanced vascular protection for high-risk patients: What’s your best option?

Enhanced vascular protection for high-risk patients: What’s your best option?

Enhanced vascular protection for high-risk patients: What’s your best option?

Patients with chronic PAD – What can be done to reduce the risk of cardiovascular and limb events?

Patients with chronic PAD – What can be done to reduce the risk of cardiovascular and limb events?

Patients with chronic PAD – What can be done to reduce the risk of cardiovascular and limb events?

Patients undergoing lower extremity revascularization: How can atherothrombotic risk be reduced?

Patients undergoing lower extremity revascularization: How can atherothrombotic risk be reduced?

Patients undergoing lower extremity revascularization: How can atherothrombotic risk be reduced?

The ACC.20/WCC Virtual Experience

The ACC.20/WCC Virtual Experience

The ACC.20/WCC Virtual Experience

From stable CAD to chronic coronary syndromes: Evolving terminology in cardiovascular disease

From stable CAD to chronic coronary syndromes: Evolving terminology in cardiovascular disease

From stable CAD to chronic coronary syndromes: Evolving terminology in cardiovascular disease

Optimizing vascular protection in high-risk patients: What do the 2019 ESC guidelines say?

Optimizing vascular protection in high-risk patients: What do the 2019 ESC guidelines say?

Optimizing vascular protection in high-risk patients: What do the 2019 ESC guidelines say?

Vascular protection in 2019: A year in review

Vascular protection in 2019: A year in review

Vascular protection in 2019: A year in review

Never miss out on the latest news!

Over 4,000 healthcare professionals have already signed up.

The next Bayer sponsored ESC-EHRA Webinar is just ahead of us and will already take place next week. Tuesday May 11, 2021 from 18:00 to 19:00 CEST

Join Prof. Roxana Mehran, Dr. Marcelo Sanmartin Fernandez and Prof. Davide Capodanno in the discussion on the topic “Management of atrial fibrillation patients undergoing PCI: where are we now?”